The Griffith Lab was quite busy during the pandemic, developing a new anti-viral peptide named “GF-19”. GF-19 shows anti-viral activity in Herpes Simplex Viral (HSV-1) models which is a virus that infects about 67% of the global population. Experiments were done and results are now published on corneal cells ( check out article here: https://www.nature.com/articles/s41598-024-53662-4 ) and rabbit models (and here: https://www.nature.com/articles/s41536-024-00355-1 ).
Our very interesting “Behind-the paper” blog post is out now! Do check it out at : https://communities.springernature.com/posts/inflammation-suppressing-cornea-in-a-syringe-with-anti-viral-gf19-peptide-promotes-regeneration-in-hsv-1-infected-rabbit-corneas
